Clinical Trial Update: Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing Rotigotine to placebo to evaluate its effect on depressive symptoms in patients with Parkinson's disease; the study has completed and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Rotigotine (Neupro) (rotigotine)

Snippet

Sponsor: UCB Korea Co., Ltd. | Conditions: Idiopathic Parkinson's Disease | Phase 4 | Status: COMPLETED | Results posted: 2015-12-18